HALO logo
halo search icon
Nkarta, Inc.

US$2.80

Price Change Indicator
0.12 (4.48%)
Nkarta, Inc.
NKTX · NAS

Nkarta, Inc.

Start Trading NKTX for Free

US$2.80

Price Arrow0.12 (4.48%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Nkarta, Inc. Overview

NKTX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About NKTX

icon
icon

Telephone

1.925.407.1049

icon

Address

1150 Veterans Boulevard, South San Francisco, CA 94080

Description

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells. The company was founded by Dario Campana in 2005 and is headquartered in South San Francisco, CA.

NKTX Price Chart

Key Stats

Market Cap

US$191.74M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.63 - 3.65

Trade Value (12mth)

US$414,892.00

1 week

1.52%

1 month

-19.28%

YTD

43.32%

1 year

57.65%

All time high

79.16

Key Fundamentals

EPS 3 yr Growth

-46.10%

EBITDA Margin

0.00%

Operating Cashflow

-$89m

Free Cash Flow Return

-20.50%

ROIC

-24.10%

Interest Coverage

0.00

Quick Ratio

12.70

Other Data

Shares Outstanding (Fully Diluted)

74m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

NKTX Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
13 May 26

NKTX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.4-1.6-1.41locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.4-1.6-1.41locklocklock
Growth
 %locklocklocklock8.133.112.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Nkarta, Inc. (NKTX:NAS)?
Halo FAQ
The current share price of Nkarta, Inc. (NKTX:NAS) is USD$2.80.
What is the 52-week high share price for Nkarta, Inc. (NKTX:NAS)?
Halo FAQ
The 52-week high share price for Nkarta, Inc. (NKTX:NAS) is USD$3.65.
What is the 52-week low share price for Nkarta, Inc. (NKTX:NAS)?
Halo FAQ
The 52-week low share price for Nkarta, Inc. (NKTX:NAS) is USD$1.63.
What is the dividend yield for Nkarta, Inc. (NKTX:NAS)?
Halo FAQ
Nkarta, Inc. (NKTX:NAS) does not pay a dividend.
What was Nkarta, Inc. (NKTX:NAS) last dividend payment?
Halo FAQ
Nkarta, Inc. (NKTX:NAS) does not pay a dividend.
What is the franking level for Nkarta, Inc. (NKTX:NAS)?
Halo FAQ
Nkarta, Inc. (NKTX:NAS) has a franking level of 0.00%.
In which sector is Nkarta, Inc. (NKTX:NAS) classified?
Halo FAQ
Nkarta, Inc. (NKTX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial